---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-26-000029"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2026-04-21T23:59:59+00:00"
generated_at: "2026-05-15T05:02:47.114434+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Intuitive Q1 rev $2.77B (+23%), EPS $2.50 non-GAAP; procedures +17%, da Vinci placements 431

## Summary
- Revenue $2.77B (+23% YoY); GAAP EPS $2.28, non-GAAP EPS $2.50 (vs. $1.92/$1.81 prior year).
- Worldwide procedures +17% YoY; da Vinci +16%, Ion +39%.
- Placed 431 da Vinci systems (vs 367), including 232 da Vinci 5 (vs 147); installed base 11,395 (+12%).
- Repurchased 2.3M shares for $1.1B in Q1; cash and investments $7.98B (down $1.05B).
- FY2026 guidance: da Vinci procedure growth 13.5%-15.5%; non-GAAP gross margin 67.5%-68.5% (incl. 1% tariff impact).

## SEC filing metadata
- accession: 0001035267-26-000029
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2026-04-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/0001035267-26-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000029/isrg-20260421.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-26-000029
- JSON: https://secwatch.observer/filing/0001035267-26-000029.json
- Plain text: https://secwatch.observer/filing/0001035267-26-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.